ArticleAMIA ... Annual Symposium proceedings. AMIA Symposium2024
Design and Evaluation of EMPATHICA: A Chatbot for Enhancing Medication Literacy.
Article in AMIA ... Annual Symposium proceedings. AMIA Symposium, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Health literacy significantly impacts patient outcomes, yet many struggle to understand complex medication information. Medication non-adherence often results from poor comprehension of drug instructions and contributes to preventable hospitalizations and poor treatment outcomes. With the increasing use of digital health interventions, AI-powered chatbots present an opportunity to improve patient access to understandable and personalized medication information. This study evaluates the usability, accessibility, and effectiveness of EMPATHICA, an AI-powered chatbot designed to provide patient-centric medication information. The study assesses whether chatbot-generated responses improve patient comprehension and engagement. The research observed the interaction between participants and the web-based application, where participants asked the chatbot to measure the chatbot's usability and accuracy using various qualitative and quantitative measures and expert physician evaluation of the responses. AI-driven chatbots have the potential to bridge health literacy gaps by providing clear and accessible medication information. By evaluating EMPATHICA, this study contributes to the growing field of AI applications supporting patient-informed medication use.
Indexed as
Identifiers
41726533PMC12919623What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.